The talks have picked up pace and the two companies are scheduled to meet this week.
Source: Merck Pushes Forward With Potential Deal for Seagen – WSJ
Merck Pushes Forward With Potential Deal for Seagen – WSJ
Related Posts
Biopharma firm Radius Health is going private in an $890m M&A deal
Radius Health, a biopharmaceutical company that has commercialized an osteoporosis drug and is developing new medicines for cancer and rare diseases, has reached an agreement to be acquired by two...
Law 360: Walgreens Inks $105M Deal To End Investor Suit Over Merger
Pharmacy chain Walgreens and two of its former executives have agreed to pay $105 million to end investor claims the company touted overly rosy financial projections as it sought shareholder...
Pfizer buys stake in French vaccine maker Valneva
US pharma group to pay €90.5mn for 8% in deal that will boost joint Lyme disease programme Source
Partners Group hires ex-CEO of Kindred Healthcare; will fundraising finally slow down?
Partners Group will announce today it is hiring Ben Breier, former CEO of Kindred Healthcare, who led the $1.4 billion sale of the healthcare provider to health insurer Source: Partners Group hires...